Skip to main content

Table 3 Comparisons between male and female OSA patients

From: Epidemiological characteristics and gender-specific differences of obstructive sleep apnea in a Chinese hypertensive population: a cross-sectional study

Variables Female Male P value
N (%) 148 (21.6) 537 (78.4)* <0.001
Age (years) 62.8 ± 10.2 58.4 ± 11.9* <0.001
BMI (Kg/m2) 26.2 ± 4.2 25.6 ± 4.1 0.136
SBP (mm Hg) 139.8 ± 21.4 136.7 ± 21.5 0.111
DBP (mm Hg) 79.1 ± 15.1 79.4 ± 14.1 0.831
AHI 18.0 ± 15.4 23.1 ± 16.8* 0.001
IVS (mm) 10.7 ± 1.8 11.6 ± 2.4* <0.001
LVPW (mm) 9.9 ± 1.6 10.7 ± 1.8* <0.001
HbA1c (%) 6.6 ± 1.4 6.2 ± 1.1* 0.001
Creatinine (μmol/L) 81.7 ± 38.7 103.7 ± 52.2* <0.001
BUN (mmol/L) 5.7 ± 3.5 5.8 ± 2.6 0.836
FPG (mmol/L) 7.0 ± 3.4 6.3 ± 2.8* 0.015
Triglyceride (mmol/L) 1.8 ± 0.2 1.8 ± 0.3 0.619
Total cholesterol (mmol/L) 4.7 ± 1.4 4.5 ± 1.2* 0.019
LDL-C (mmol/L) 2.8 ± 1.1 2.7 ± 0.9 0.092
HDL-C (mmol/L) 1.1 ± 0.3 1.0 ± 0.2 0.947
Proteinuria (%) 14.9 21.9 0.289
Diabetes mellitus (%) 33.8 21.8* 0.003
Dyslipidemia (%) 23.0 12.3* 0.001
Aortic dissection (%) 10.8 22.3* 0.002
Aneurysm (%) 1.4 6.5* 0.014
CHD (%) 37.8 43.0 0.258
Cerebrovascular disease (%) 12.8 9.1 0.181
Heart failure (%) 25.0 21.0 0.303
Atrial fibrillation (%) 12.8 8.0 0.070
HCM (%) 4.1 3.2 0.595
Anti-platelet (%) 55.4 54.0 0.762
Statins (%) 68.2 66.5 0.687
ACEI (%) 19.6 22.7 0.417
ARB (%) 43.2 46.7 0.450
Beta-blocker (%) 60.8 68.0 0.102
Alpha-blocker (%) 3.4 7.3 0.088
CCB (%) 60.8 56.1 0.300
Diuretic (%) 18.9 18.6 0.935
Warfarin (%) 10.1 6.3 0.112
  1. Denote: BUN blood uria nitrogen, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, CHD coronary heart disease, HCM hypertrophy cardiomyopahty, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker
  2. *P < 0.05 versus female group